Taurolidine
- Level
- Commodity
- Parent
- 51101600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51101618This classification denotes an antibiotic with the molecular formula C7H16N4O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8OBZ1M4V3V, chemically known as 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine 1,1-dioxide) but generally known as taurolidine, which bears US NIH Compound Identifier 29566. European Medicines Agency schedules Taurolidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10837MIG. The term TAUROLIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). World Health Organization schedules taurolidine in its Anatomical Therapeutic Chemical (ATC) Classification. TAUROLIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule taurolidine under HS 29349990 and SITC 51579. As of Q4 2014, TAUROLIDINE remains the US FDA Preferred Term for this commodity. Taurolidine bears US NLM identifiers UMLS ID C0144567 and NCI Concept Code C2639. SMILES: S1(=O)(=O)NCN(CN2CCS(=O)(=O)NC2)CC1.
Same parent
Under 51101600 · 77Activities that produce or sell this
KBLI · 8Inherited from family 51100000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.